“Valsartan: Come Versatilità E Tollerabilità Possono Contribuireal Contenimento Della Spesa Sanitaria”. Farmeconomia. Health economics and therapeutic pathways 12, no. 1S (March 15, 2011): 9–17. Accessed October 29, 2025. https://journals.seedstm.com/index.php/FE/article/view/997.